Guardant Health Inc
Guardant Health Inc (GH) Implied Volatility Current
GH implied volatility is 58%. IV Rank is 31%, placing current premiums in the middle of their 52-week range.
Read more
Tracking GH implied volatility helps you identify when options premiums on Guardant Health Inc are historically cheap or expensive, and where the best trades are hiding. Guardant Health Inc implied volatility reflects the market's expectation of future price movement: when GH IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Guardant Health Inc's implied volatility current levels in real time and filter for high-probability trades.
Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For GH, tracking metrics like GH IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on GH signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy dataset of advanced cancer patients. It is also developing LUNAR-2 test for the early detection of colorectal cancer in asymptomatic individuals eligible; and GuardantConnect, an integrated software-based solution for clinical and biopharmaceutical customers seeking to connect patients tested with the Guardant360 assay with actionable alterations with potentially relevant clinical trials.
In addition, the company offers Guardant Reveal Test for neoadjuvant and adjuvant treatment selection in early-stage cancer patients; Guardant360 tissue genotyping product; and Guardant-19 for use in the detection of the novel coronavirus. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, and kits fulfillment related services to biopharmaceutical companies and medical institutions. The company was incorporated in 2011 and is headquartered in Redwood City, California.
Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where GH implied volatility sits today versus where it has been. Our scanner ranks Guardant Health Inc implied volatility against its historical range, surfaces extremes in GH IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Guardant Health Inc IV is rich or cheap — measure it, then act on it.
Implied Volatility
IV is below its typical range - premiums look reasonable for buyers.
As of September 15, 2026
Trade options with IV on your side
Track GH IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.
Start your 14-day free trial→